Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Journal of Diabetes Investigation|May 21, 2014
Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complicationsTakeshi Matsumura, Kayo Taketa, Seiya Shimoda, et al.
Endocrinology, Diabetes & Metabolism Case Reports|May 14, 2015
A rare case showing subacute thyroiditis-like symptoms with amyloid goiter after anti-tumor necrosis factor therapyJunji Kawashima, Hideaki Naoe, Yutaka Sasaki, et al.
The Journal of Physiology|April 15, 2006
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancerHiroyuki Motoshima, Barry J Goldstein, Motoyuki Igata, et al.
World Journal of Gastroenterology|September 3, 2009
What is artificial endocrine pancreas? Mechanism and historyKenro Nishida, Seiya Shimoda, Kenshi Ichinose, et al.
Advances in Therapy|September 5, 2019
Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised TrialEiichi Araki, Yuriko Unno, Yuko Tanaka, et al.
Biomedicines|February 26, 2025
Age-Related Glucose Intolerance Is Associated with Impaired Insulin Secretion in Community-Dwelling Japanese Adults: The Kumamoto Koshi StudyKazuki Fukuda, Masaki Haneda, Naoto Kubota, et al.
Rinsho Shinkeigaku = Clinical Neurology|August 5, 2010
[A case of Lissauer form of paretic neurosyphilis with drop attacks and dementia]Taisaku Syouzaki, Sou Arahata, Eiichi Araki, et al.
Diabetes, Obesity & Metabolism|December 18, 2016
Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trialEiichi Araki, Yukiko Onishi, Michiko Asano, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 7, 2019
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus TherapyJakob Langer, Michael L Wolden, Seiya Shimoda, et al.
Journal of Atherosclerosis and Thrombosis|April 10, 2018
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized TrialHidenori Arai, Shizuya Yamashita, Koutaro Yokote, et al.
Pageof 21